RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Advanz Pharma Corp Stock

Advanz Pharma Corp ROA 2024

Advanz Pharma Corp ROA

0

Ticker

CXRXF

ISIN

JE00BJVH6L55

WKN

A2PYQF

In 2024, Advanz Pharma Corp's return on assets (ROA) was 0, a 0% increase from the 0 ROA in the previous year.

Advanz Pharma Corp Aktienanalyse

What does Advanz Pharma Corp do?

Advanz Pharma Corp Ltd is an international pharmaceutical company that focuses on the development, manufacturing, and marketing of generics and specialty pharmaceuticals. The company is headquartered in London and operates numerous subsidiaries worldwide. Answer: Advanz Pharma Corp Ltd is an international pharmaceutical company that specializes in developing, manufacturing, and marketing generics and specialty pharmaceuticals. It was founded in 2015 through the merger of two well-known generic drug manufacturers: Canadian company Concordia International Corp and Irish company Warner Chilcott plc. Advanz Pharma is listed on the Bombay Stock Exchange and the National Stock Exchange of India since 2017. Answer: Advanz Pharma has its own business model that emphasizes the marketing and development of generics and specialty pharmaceuticals. The company focuses on providing cost-effective medical solutions by producing generic versions of products whose patent has expired or is about to expire. These medications are typically more affordable than their original counterparts. However, the company also manufactures specialty pharmaceuticals that specialize in rare diseases, oncology, and hormonal disorders. Answer: Advanz Pharma is divided into several divisions to produce various types of medications, such as: - Cardiology - Oncology - Gastroenterology - Neurology - Antibiotics - Diabetic care - Endocrinology and reproduction Answer: Advanz Pharma manufactures a wide range of generics and specialty pharmaceuticals. Some of the products include: - Metformin, an antidiabetic medication - Carbidopa/levodopa, a medication for treating Parkinson's disease - Ezetimibe, for lowering cholesterol levels - Doxorubicin, a cancer medication - Hydroxyzine, an antiallergic medication - Methotrexate, a cancer and rheumatoid arthritis medication Answer: In conclusion, Advanz Pharma Corp Ltd is an international generics and specialty pharmaceutical company that focuses on the development, manufacturing, and marketing of cost-effective medications. The company has a broad product portfolio that includes both generics and specialized medications. It aims to provide cost-effective solutions to improve access to essential healthcare. Advanz Pharma Corp ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Advanz Pharma Corp's Return on Assets (ROA)

Advanz Pharma Corp's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Advanz Pharma Corp's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Advanz Pharma Corp's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Advanz Pharma Corp’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Advanz Pharma Corp stock

What is the Return on Assets (ROA) of Advanz Pharma Corp this year?

The Return on Assets (ROA) of Advanz Pharma Corp is 0 undefined this year.

What was the ROA of Advanz Pharma Corp compared to the previous year?

The ROA of Advanz Pharma Corp has increased by 0% compared to the previous year.

What consequences do high ROA have for investors of Advanz Pharma Corp?

A high ROA is advantageous for investors of Advanz Pharma Corp, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Advanz Pharma Corp?

A low ROA can be unfavorable for investors of Advanz Pharma Corp as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Advanz Pharma Corp affect the company?

An increase in ROA of Advanz Pharma Corp can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Advanz Pharma Corp impact the company?

A reduction in the ROA of Advanz Pharma Corp can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Advanz Pharma Corp?

Some factors that can influence the ROA of Advanz Pharma Corp include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Advanz Pharma Corp important for investors?

The ROA of Advanz Pharma Corp is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Advanz Pharma Corp take to improve ROA?

To improve ROA, Advanz Pharma Corp can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Advanz Pharma Corp pay?

Over the past 12 months, Advanz Pharma Corp paid a dividend of 67.5 USD . This corresponds to a dividend yield of about 395.66 %. For the coming 12 months, Advanz Pharma Corp is expected to pay a dividend of 0 USD.

What is the dividend yield of Advanz Pharma Corp?

The current dividend yield of Advanz Pharma Corp is 395.66 %.

When does Advanz Pharma Corp pay dividends?

Advanz Pharma Corp pays a quarterly dividend. This is distributed in the months of November, February, May, August.

How secure is the dividend of Advanz Pharma Corp?

Advanz Pharma Corp paid dividends every year for the past 0 years.

What is the dividend of Advanz Pharma Corp?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Advanz Pharma Corp located?

Advanz Pharma Corp is assigned to the 'Health' sector.

Wann musste ich die Aktien von Advanz Pharma Corp kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Advanz Pharma Corp from 7/29/2016 amounting to 0.075 USD, you needed to have the stock in your portfolio before the ex-date on 7/13/2016.

When did Advanz Pharma Corp pay the last dividend?

The last dividend was paid out on 7/29/2016.

What was the dividend of Advanz Pharma Corp in the year 2023?

In the year 2023, Advanz Pharma Corp distributed 0 USD as dividends.

In which currency does Advanz Pharma Corp pay out the dividend?

The dividends of Advanz Pharma Corp are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Advanz Pharma Corp

Our stock analysis for Advanz Pharma Corp Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Advanz Pharma Corp Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.